Abstract
Summary
Simeglutide was originally introduced to the market as a drug for the treatment of type 2 diabetes, but some studies have shown that it is also effective for weight loss. Oral Simeglutide is specifically developed for oral use. The bottom three companies on the list are all in development.
The global Oral Simeglutide market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Oral Simeglutide Industry Forecast” looks at past sales and reviews total world Oral Simeglutide sales in 2023, providing a comprehensive analysis by region and market sector of projected Oral Simeglutide sales for 2024 through 2030. With Oral Simeglutide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Simeglutide industry.
This Insight Report provides a comprehensive analysis of the global Oral Simeglutide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Simeglutide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Simeglutide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Simeglutide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Simeglutide.
United States market for Oral Simeglutide is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Oral Simeglutide is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Oral Simeglutide is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Oral Simeglutide players cover Novo Nordisk A/S, Aurisco, Shanghai Benemae Pharmaceutical, Hangzhou Jiuyuan Genetic Engineering Co., Ltd. and Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. and etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Simeglutide market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Tablets
Compulse
Segmentation by application
Online
Offline
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novo Nordisk A/S
Aurisco
Shanghai Benemae Pharmaceutical
Hangzhou Jiuyuan Genetic Engineering Co., Ltd.
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Livzon Pharmaceutical Group Inc.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Oral Simeglutide market?
What factors are driving Oral Simeglutide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Simeglutide market opportunities vary by end market size?
How does Oral Simeglutide break out type, application?
The global Oral Simeglutide market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Oral Simeglutide Industry Forecast” looks at past sales and reviews total world Oral Simeglutide sales in 2023, providing a comprehensive analysis by region and market sector of projected Oral Simeglutide sales for 2024 through 2030. With Oral Simeglutide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Simeglutide industry.
This Insight Report provides a comprehensive analysis of the global Oral Simeglutide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Simeglutide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Simeglutide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Simeglutide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Simeglutide.
United States market for Oral Simeglutide is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Oral Simeglutide is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Oral Simeglutide is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Oral Simeglutide players cover Novo Nordisk A/S, Aurisco, Shanghai Benemae Pharmaceutical, Hangzhou Jiuyuan Genetic Engineering Co., Ltd. and Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. and etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Simeglutide market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Tablets
Compulse
Segmentation by application
Online
Offline
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novo Nordisk A/S
Aurisco
Shanghai Benemae Pharmaceutical
Hangzhou Jiuyuan Genetic Engineering Co., Ltd.
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Livzon Pharmaceutical Group Inc.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Oral Simeglutide market?
What factors are driving Oral Simeglutide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Simeglutide market opportunities vary by end market size?
How does Oral Simeglutide break out type, application?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Simeglutide Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Oral Simeglutide by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Oral Simeglutide by Country/Region, 2019, 2023 & 2030
2.2 Oral Simeglutide Segment by Type
2.2.1 Tablets
2.2.2 Compulse
2.3 Oral Simeglutide Sales by Type
2.3.1 Global Oral Simeglutide Sales Market Share by Type (2019-2024)
2.3.2 Global Oral Simeglutide Revenue and Market Share by Type (2019-2024)
2.3.3 Global Oral Simeglutide Sale Price by Type (2019-2024)
2.4 Oral Simeglutide Segment by Application
2.4.1 Online
2.4.2 Offline
2.5 Oral Simeglutide Sales by Application
2.5.1 Global Oral Simeglutide Sale Market Share by Application (2019-2024)
2.5.2 Global Oral Simeglutide Revenue and Market Share by Application (2019-2024)
2.5.3 Global Oral Simeglutide Sale Price by Application (2019-2024)
3 Global Oral Simeglutide by Company
3.1 Global Oral Simeglutide Breakdown Data by Company
3.1.1 Global Oral Simeglutide Annual Sales by Company (2019-2024)
3.1.2 Global Oral Simeglutide Sales Market Share by Company (2019-2024)
3.2 Global Oral Simeglutide Annual Revenue by Company (2019-2024)
3.2.1 Global Oral Simeglutide Revenue by Company (2019-2024)
3.2.2 Global Oral Simeglutide Revenue Market Share by Company (2019-2024)
3.3 Global Oral Simeglutide Sale Price by Company
3.4 Key Manufacturers Oral Simeglutide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Simeglutide Product Location Distribution
3.4.2 Players Oral Simeglutide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oral Simeglutide by Geographic Region
4.1 World Historic Oral Simeglutide Market Size by Geographic Region (2019-2024)
4.1.1 Global Oral Simeglutide Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Oral Simeglutide Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Oral Simeglutide Market Size by Country/Region (2019-2024)
4.2.1 Global Oral Simeglutide Annual Sales by Country/Region (2019-2024)
4.2.2 Global Oral Simeglutide Annual Revenue by Country/Region (2019-2024)
4.3 Americas Oral Simeglutide Sales Growth
4.4 APAC Oral Simeglutide Sales Growth
4.5 Europe Oral Simeglutide Sales Growth
4.6 Middle East & Africa Oral Simeglutide Sales Growth
5 Americas
5.1 Americas Oral Simeglutide Sales by Country
5.1.1 Americas Oral Simeglutide Sales by Country (2019-2024)
5.1.2 Americas Oral Simeglutide Revenue by Country (2019-2024)
5.2 Americas Oral Simeglutide Sales by Type
5.3 Americas Oral Simeglutide Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Simeglutide Sales by Region
6.1.1 APAC Oral Simeglutide Sales by Region (2019-2024)
6.1.2 APAC Oral Simeglutide Revenue by Region (2019-2024)
6.2 APAC Oral Simeglutide Sales by Type
6.3 APAC Oral Simeglutide Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oral Simeglutide by Country
7.1.1 Europe Oral Simeglutide Sales by Country (2019-2024)
7.1.2 Europe Oral Simeglutide Revenue by Country (2019-2024)
7.2 Europe Oral Simeglutide Sales by Type
7.3 Europe Oral Simeglutide Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral Simeglutide by Country
8.1.1 Middle East & Africa Oral Simeglutide Sales by Country (2019-2024)
8.1.2 Middle East & Africa Oral Simeglutide Revenue by Country (2019-2024)
8.2 Middle East & Africa Oral Simeglutide Sales by Type
8.3 Middle East & Africa Oral Simeglutide Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Simeglutide
10.3 Manufacturing Process Analysis of Oral Simeglutide
10.4 Industry Chain Structure of Oral Simeglutide
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Simeglutide Distributors
11.3 Oral Simeglutide Customer
12 World Forecast Review for Oral Simeglutide by Geographic Region
12.1 Global Oral Simeglutide Market Size Forecast by Region
12.1.1 Global Oral Simeglutide Forecast by Region (2025-2030)
12.1.2 Global Oral Simeglutide Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral Simeglutide Forecast by Type
12.7 Global Oral Simeglutide Forecast by Application
13 Key Players Analysis
13.1 Novo Nordisk A/S
13.1.1 Novo Nordisk A/S Company Information
13.1.2 Novo Nordisk A/S Oral Simeglutide Product Portfolios and Specifications
13.1.3 Novo Nordisk A/S Oral Simeglutide Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Novo Nordisk A/S Main Business Overview
13.1.5 Novo Nordisk A/S Latest Developments
13.2 Aurisco
13.2.1 Aurisco Company Information
13.2.2 Aurisco Oral Simeglutide Product Portfolios and Specifications
13.2.3 Aurisco Oral Simeglutide Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Aurisco Main Business Overview
13.2.5 Aurisco Latest Developments
13.3 Shanghai Benemae Pharmaceutical
13.3.1 Shanghai Benemae Pharmaceutical Company Information
13.3.2 Shanghai Benemae Pharmaceutical Oral Simeglutide Product Portfolios and Specifications
13.3.3 Shanghai Benemae Pharmaceutical Oral Simeglutide Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Shanghai Benemae Pharmaceutical Main Business Overview
13.3.5 Shanghai Benemae Pharmaceutical Latest Developments
13.4 Hangzhou Jiuyuan Genetic Engineering Co., Ltd.
13.4.1 Hangzhou Jiuyuan Genetic Engineering Co., Ltd. Company Information
13.4.2 Hangzhou Jiuyuan Genetic Engineering Co., Ltd. Oral Simeglutide Product Portfolios and Specifications
13.4.3 Hangzhou Jiuyuan Genetic Engineering Co., Ltd. Oral Simeglutide Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Hangzhou Jiuyuan Genetic Engineering Co., Ltd. Main Business Overview
13.4.5 Hangzhou Jiuyuan Genetic Engineering Co., Ltd. Latest Developments
13.5 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
13.5.1 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Company Information
13.5.2 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Oral Simeglutide Product Portfolios and Specifications
13.5.3 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Oral Simeglutide Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Main Business Overview
13.5.5 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Latest Developments
13.6 Livzon Pharmaceutical Group Inc.
13.6.1 Livzon Pharmaceutical Group Inc. Company Information
13.6.2 Livzon Pharmaceutical Group Inc. Oral Simeglutide Product Portfolios and Specifications
13.6.3 Livzon Pharmaceutical Group Inc. Oral Simeglutide Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Livzon Pharmaceutical Group Inc. Main Business Overview
13.6.5 Livzon Pharmaceutical Group Inc. Latest Developments
14 Research Findings and Conclusion